Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania

Sarah Kawasaki, Erica Francis, Sara Mills, Glenn Buchberger, Ruth Hogentogler, Jennifer Kraschnewski

Research output: Contribution to journalArticle

Abstract

Pennsylvania has the third highest rate of death due to drug overdose (44.3 per 100,000) in the country, which is significantly higher than the national rate. This continues to have drastic societal impact. Medication assisted treatment (MAT), which includes opioid agonist medications, is the gold standard in treatment for OUD; however, a significant gap remains between the number of individuals in need of treatment and the number of MAT providers. Penn State Health established a system to address the opioid epidemic through the Pennsylvania Coordinated Medication Assisted Treatment program utilizing lessons learned from existing validated models. Connecting primary care sites and hospital systems through a combination of Hub and Spoke, bridge clinic services provided at the Hub, peer recovery services, Project Extension for Community Health Outcomes (ECHO), and layered emergency department (ED) initiation of buprenorphine, this model is an innovative approach that addresses many known barriers to MAT treatment initiation. Early results within the first six months indicate significantly shortened wait time for patients seeking treatment, provision of waiver training to 70 local physicians to prescribe buprenorphine, and improved knowledge and ability to provide patient care for providers participating in our first Project ECHO cohort.

Original languageEnglish (US)
Pages (from-to)58-64
Number of pages7
JournalJournal of Substance Abuse Treatment
Volume106
DOIs
StatePublished - Nov 2019

Fingerprint

Opioid Analgesics
Buprenorphine
Therapeutics
Health
Drug Overdose
Hospital Emergency Service
Primary Health Care
Patient Care
Physicians
Mortality

All Science Journal Classification (ASJC) codes

  • Phychiatric Mental Health
  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

@article{798bbc38c92a434abdeeed32d613a45b,
title = "Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania",
abstract = "Pennsylvania has the third highest rate of death due to drug overdose (44.3 per 100,000) in the country, which is significantly higher than the national rate. This continues to have drastic societal impact. Medication assisted treatment (MAT), which includes opioid agonist medications, is the gold standard in treatment for OUD; however, a significant gap remains between the number of individuals in need of treatment and the number of MAT providers. Penn State Health established a system to address the opioid epidemic through the Pennsylvania Coordinated Medication Assisted Treatment program utilizing lessons learned from existing validated models. Connecting primary care sites and hospital systems through a combination of Hub and Spoke, bridge clinic services provided at the Hub, peer recovery services, Project Extension for Community Health Outcomes (ECHO), and layered emergency department (ED) initiation of buprenorphine, this model is an innovative approach that addresses many known barriers to MAT treatment initiation. Early results within the first six months indicate significantly shortened wait time for patients seeking treatment, provision of waiver training to 70 local physicians to prescribe buprenorphine, and improved knowledge and ability to provide patient care for providers participating in our first Project ECHO cohort.",
author = "Sarah Kawasaki and Erica Francis and Sara Mills and Glenn Buchberger and Ruth Hogentogler and Jennifer Kraschnewski",
year = "2019",
month = "11",
doi = "10.1016/j.jsat.2019.08.016",
language = "English (US)",
volume = "106",
pages = "58--64",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",

}

Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania. / Kawasaki, Sarah; Francis, Erica; Mills, Sara; Buchberger, Glenn; Hogentogler, Ruth; Kraschnewski, Jennifer.

In: Journal of Substance Abuse Treatment, Vol. 106, 11.2019, p. 58-64.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania

AU - Kawasaki, Sarah

AU - Francis, Erica

AU - Mills, Sara

AU - Buchberger, Glenn

AU - Hogentogler, Ruth

AU - Kraschnewski, Jennifer

PY - 2019/11

Y1 - 2019/11

N2 - Pennsylvania has the third highest rate of death due to drug overdose (44.3 per 100,000) in the country, which is significantly higher than the national rate. This continues to have drastic societal impact. Medication assisted treatment (MAT), which includes opioid agonist medications, is the gold standard in treatment for OUD; however, a significant gap remains between the number of individuals in need of treatment and the number of MAT providers. Penn State Health established a system to address the opioid epidemic through the Pennsylvania Coordinated Medication Assisted Treatment program utilizing lessons learned from existing validated models. Connecting primary care sites and hospital systems through a combination of Hub and Spoke, bridge clinic services provided at the Hub, peer recovery services, Project Extension for Community Health Outcomes (ECHO), and layered emergency department (ED) initiation of buprenorphine, this model is an innovative approach that addresses many known barriers to MAT treatment initiation. Early results within the first six months indicate significantly shortened wait time for patients seeking treatment, provision of waiver training to 70 local physicians to prescribe buprenorphine, and improved knowledge and ability to provide patient care for providers participating in our first Project ECHO cohort.

AB - Pennsylvania has the third highest rate of death due to drug overdose (44.3 per 100,000) in the country, which is significantly higher than the national rate. This continues to have drastic societal impact. Medication assisted treatment (MAT), which includes opioid agonist medications, is the gold standard in treatment for OUD; however, a significant gap remains between the number of individuals in need of treatment and the number of MAT providers. Penn State Health established a system to address the opioid epidemic through the Pennsylvania Coordinated Medication Assisted Treatment program utilizing lessons learned from existing validated models. Connecting primary care sites and hospital systems through a combination of Hub and Spoke, bridge clinic services provided at the Hub, peer recovery services, Project Extension for Community Health Outcomes (ECHO), and layered emergency department (ED) initiation of buprenorphine, this model is an innovative approach that addresses many known barriers to MAT treatment initiation. Early results within the first six months indicate significantly shortened wait time for patients seeking treatment, provision of waiver training to 70 local physicians to prescribe buprenorphine, and improved knowledge and ability to provide patient care for providers participating in our first Project ECHO cohort.

UR - http://www.scopus.com/inward/record.url?scp=85071549555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071549555&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2019.08.016

DO - 10.1016/j.jsat.2019.08.016

M3 - Article

C2 - 31540612

AN - SCOPUS:85071549555

VL - 106

SP - 58

EP - 64

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

ER -